Author:
Kuang Ye-Hong,Zhu Wu,Lin Ge,Cheng La-Mei,Qin Qun,Huang Zhi-Jun,Shi Yu-Ling,Zhang Chun-Lei,Xu Jin-Hua,Yan Ke-Xiang,Lv Cheng-Zhi,Li Wei,Han Qin,Stambler Ilia,Lim Lee Wei,Chakrabarti Sasanka,Ulfhake Brun,Min Kyung-Jin,Ellison-Hughes Georgina,Cho William C,Jin Kunlin,Yao Danni,Lu Chuanjian,Zhao Robert Chunhua,Chen Xiang
Reference83 articles.
1. Lovell-Badge R, Anthony E, Barker RA, Bubela T, Brivanlou AH, Carpenter M, et al. (2021). ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. Stem Cell Reports, 16:1398-1408.
2. Poznanski WJ, Waheed I, Van R (1973). Human fat cell precursors. Morphologic and metabolic differentiation in culture. Lab Invest, 29:570-576.
3. Si Z, Wang X, Sun C, Kang Y, Xu J, Wang X, et al. (2019). Adipose-derived stem cells: Sources, potency, and implications for regenerative therapies. Biomed Pharmacother, 114:108765.
4. De Jesus MM, Santiago JS, Trinidad CV, See ME, Semon KR, Fernandez MO, Jr., et al. (2016). Autologous Adipose-Derived Mesenchymal Stromal Cells for the Treatment of Psoriasis Vulgaris and Psoriatic Arthritis: A Case Report. Cell Transplant, 25:2063-2069.
5. Bajouri A, Dayani D, Taj Sharghi A, Karimi S, Niknezhadi M, Moeinabadi Bidgoli K, et al. (2023). Subcutaneous Injection of Allogeneic Adipose-Derived Mesenchymal Stromal Cells in Psoriasis Plaques: Clinical Trial Phase I. Cell J, 25:363-371.